KIDINS220 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.997800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.031200E-01
Normal-vs-Stage2
2.526600E-01
Normal-vs-Stage3
2.304500E-02
Normal-vs-Stage4
6.929400E-01
Stage1-vs-Stage2
5.059200E-01
Stage1-vs-Stage3
4.380400E-02
Stage1-vs-Stage4
2.473000E-01
Stage2-vs-Stage3
1.394630E-01
Stage2-vs-Stage4
6.660300E-02
Stage3-vs-Stage4
1.176300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.849600E-01
Normal-vs-AfricanAmerican
6.416200E-01
Normal-vs-Asian
1.251190E-01
Caucasian-vs-AfricanAmerican
5.140400E-01
Caucasian-vs-Asian
2.636200E-01
AfricanAmerican-vs-Asian
2.366600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.905400E-01
Normal-vs-Female
3.307800E-01
Male-vs-Female
6.554400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.877600E-01
Normal-vs-Age(41-60Yrs)
5.753800E-01
Normal-vs-Age(61-80Yrs)
2.448200E-01
Normal-vs-Age(81-100Yrs)
3.746200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.617800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.822300E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.629600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.831590E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.867570E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.413800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.564100E-02
Normal-vs-Daily Drinker
1.257630E-01
Normal-vs-Weekly Drinker
1.649000E-01
Normal-vs-Occasional Drinker
7.851400E-01
Normal-vs-Social Drinker
7.169200E-01
Non Drinker-vs-Daily Drinker
9.753800E-01
Non Drinker-vs-Weekly Drinker
7.202800E-01
Non Drinker-vs-Occasional Drinker
5.996200E-02
Non Drinker-vs-Social Drinker
1.654390E-01
Daily Drinker-vs-Weekly Drinker
7.335600E-01
Daily Drinker-vs-Occasional Drinker
6.064300E-02
Daily Drinker-vs-Social Drinker
1.408010E-01
Weekly Drinker-vs-Occasional Drinker
1.632220E-01
Weekly Drinker-vs-Social Drinker
2.906600E-01
Occasional Drinker-vs-Social Drinker
8.330000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.904200E-02
Normal-vs-Grade 2
9.337600E-03
Normal-vs-Grade 3
1.519840E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.341200E-01
Grade 1-vs-Grade 3
5.767200E-01
Grade 1-vs-Grade 4
7.904200E-02
Grade 2-vs-Grade 3
7.252800E-01
Grade 2-vs-Grade 4
9.337600E-03
Grade 3-vs-Grade 4
1.519840E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.965760E-01
Normal-vs-NonDiabetic
2.445200E-01
Diabetic-vs-NonDiabetic
5.531800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.942200E-02
Normal-vs-NoPancreatitis
2.743800E-01
Pancreatitis-vs-NoPancreatitis
2.876600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.851000E-01
Normal-vs-N1
2.742600E-01
N0-vs-N1
9.386400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.340600E-01
Normal-vs-TP53-NonMutant
4.739800E-01
TP53-Mutant-vs-TP53-NonMutant
6.278800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
